Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

Autoria(s): Scarabin, P.Y.; Arveiler, D.; Amouyel, P.; Santos, C.D.; Evans, Alun; Luc, G.; Ferrieres, J.; Juhan Vague, I.
Data(s)

01/01/2003
Formato

application/pdf
Identificador

http://pure.qub.ac.uk/portal/en/publications/plasma-fibrinogen-explains-much-of-the-difference-in-risk-of-coronary-heart-disease-between-france-and-northern-ireland-the-prime-study(a85334ea-2d5a-4158-8f0b-fe1d5dd658b3).html

http://pure.qub.ac.uk/ws/files/755399/Plasma%20fibrinogen%20explains%20much%20of%20the%20difference%20in%20risk%20of%20coronary%20heart%20disease%20between%20France%20and%20Northern%20Ireland%20-The%20PRIME%20study%20-%20At.pdf
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Scarabin , P Y , Arveiler , D , Amouyel , P , Santos , C D , Evans , A , Luc , G , Ferrieres , J & Juhan Vague , I 2003 , ' Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study ' Atherosclerosis , vol 166 , no. 1 , pp. 103-109 .
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2705 #Cardiology and Cardiovascular Medicine
Tipo

article
Acesso ao item digital